These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8430056)

  • 1. Pharmacokinetics of stereomeric 1,4:3,6-dianhydrohexitol mononitrates in rats.
    Tzeng TB; Fung HL
    Pharm Res; 1993 Jan; 10(1):22-7. PubMed ID: 8430056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of oral L-isoidide mononitrate in rats.
    Tzeng TB; Fung HL
    Biopharm Drug Dispos; 1993 Oct; 14(7):589-94. PubMed ID: 8251613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gas chromatographic analysis of isomeric organic mononitrates in plasma.
    Tzeng TB; Fung HL
    J Chromatogr; 1991 Nov; 571(1-2):109-20. PubMed ID: 1810940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoselective pharmacokinetics and pharmacodynamics of organic nitrates in rats.
    Hatanaka T; Ihara K; Kodera M; Katayama K; Koizumi T
    J Pharmacol Exp Ther; 2001 Jul; 298(1):346-53. PubMed ID: 11408561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic modeling of the in vitro vasodilating effects of organic mononitrates.
    Tzeng TB; Fung HL
    J Pharmacokinet Biopharm; 1992 Jun; 20(3):227-51. PubMed ID: 1326039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isosorbide 5-mononitrate and isosorbide 2-mononitrate kinetics after intravenous and oral dosing.
    Straehl P; Galeazzi RL; Soliva M
    Clin Pharmacol Ther; 1984 Oct; 36(4):485-92. PubMed ID: 6478734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of isosorbide dinitrate and isosorbide-5-mononitrate.
    Schaumann W
    Int J Clin Pharmacol Ther Toxicol; 1989 Sep; 27(9):445-53. PubMed ID: 2681004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetics of nitrates.
    Bogaert MG
    Cardiovasc Drugs Ther; 1994 Oct; 8(5):693-9. PubMed ID: 7873466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic/pharmacodynamic relationship of the duration of vasodilating action of organic mononitrates in rats.
    Tzeng TB; Fung HL
    J Pharmacol Exp Ther; 1992 May; 261(2):692-700. PubMed ID: 1578380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral absorption and disposition of isosorbide dinitrate and isosorbide mononitrates in man.
    Laufen H; Aumann M; Leitold M
    Arzneimittelforschung; 1983; 33(7):980-4. PubMed ID: 6684933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentrations of isosorbide dinitrate, isosorbide-2-mononitrate and isosorbide-5-mononitrate in human vascular and muscle tissue under steady-state conditions.
    Schneider W; Menke G; Heidemann R; Satter P; Kaltenbach M; Rietbrock N
    Eur J Clin Pharmacol; 1990; 38(2):145-7. PubMed ID: 2338111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of isosorbide mononitrate.
    Abshagen UW
    Am J Cardiol; 1992 Nov; 70(17):61G-66G. PubMed ID: 1449102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isosorbide, isomannide and isoidide dinitrate: urinary excretion in the rat.
    Rosseel MT; Bogaert MG
    Biochem Pharmacol; 1973 Jan; 22(1):67-72. PubMed ID: 4763246
    [No Abstract]   [Full Text] [Related]  

  • 14. Determination of isosorbide dinitrate and its mononitrate metabolites in human plasma using Extrelut purification and capillary column gas-liquid chromatography.
    Santoni Y; Rolland PH; Cano JP
    J Chromatogr; 1984 Mar; 306():165-72. PubMed ID: 6715456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex-related differences in the pharmacokinetics of isosorbide-5-mononitrate (60 mg) after repeated oral administration of two different original prolonged release formulations.
    Vree TB; Dammers E; Valducci R
    Int J Clin Pharmacol Ther; 2004 Aug; 42(8):463-72. PubMed ID: 15366327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of isosorbide-5-mononitrate in plasma by GC-ECD and study on its pharmacokinetics in ten volunteers].
    Yang LL; Yuan YS; Zhao FL
    Yao Xue Xue Bao; 1997 Oct; 32(10):773-6. PubMed ID: 11596222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gas chromatographic method with EC detection to determine isosorbide-5-mononitrate (IS-5-MN) in human serum and its pharmacokinetic parameters].
    Xia GZ; Fu YK; Dong SN; Li R
    Yao Xue Xue Bao; 1994; 29(8):634-8. PubMed ID: 7985521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isosorbide 5-mononitrate pharmacokinetics in humans.
    Taylor T; Chasseaud LF; Major R; Doyle E; Darragh A
    Biopharm Drug Dispos; 1981; 2(3):255-63. PubMed ID: 7295882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and metabolism of isosorbide-dinitrate after intravenous and oral administration.
    Abshagen U; Betzien G; Endele R; Kaufmann B; Neugebauer G
    Eur J Clin Pharmacol; 1985; 27(6):637-44. PubMed ID: 3987768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of penetration enhancers on isosorbide dinitrate penetration through rat skin from a transdermal therapeutic system.
    Gabiga H; Cal K; Janicki S
    Int J Pharm; 2000 Apr; 199(1):1-6. PubMed ID: 10794921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.